Metabolic changes after growth hormone treatment in children with growth hormone deficiency and small for gestational age: LG observational study.

What Was Tested

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this observational study publication.

Children with growth hormone deficiency (GHD) and small for gestational age (SGA) have major growth and metabolic issues.

However, the long-term metabolic effects of this treatment remain unclear.

This study aimed to investigate metabolic changes after GH treatment in children with GHD and SGA.

Who Took Part

The study group was 1,788 patients.

The age groups tagged for this paper are young children and children, both men and women.

The study population included 1,788 patients: 1,364 with GHD, 318 with SGA, and 106 with GHD and SGA.

What Was Measured

PubMed files the paper under topics including Infant, Small for Gestational Age, Human Growth Hormone, Body Height, Body Mass Index and Growth Disorders.

The authors tagged it with the keywords glucose metabolism, linear growth, lipid profile, metabolic health, retrospective study and short stature in children.

What This Means in Plain Language

This is an observational study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 1,788 patients.

With several hundred people or more, it is a fairly large study for this kind of research.

The abstract goes on to report its results in about 7 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2025 (Frontiers in endocrinology), a journal based in Switzerland.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.